These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28718965)

  • 21. Mechanisms of allergen-specific immunotherapy.
    Akdis M; Akdis CA
    J Allergy Clin Immunol; 2007 Apr; 119(4):780-91. PubMed ID: 17321578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance.
    Burton OT; Tamayo JM; Stranks AJ; Koleoglou KJ; Oettgen HC
    J Allergy Clin Immunol; 2018 Jan; 141(1):189-201.e3. PubMed ID: 28479335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.
    Lawrence MG; Steinke JW; Borish L
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):138-42. PubMed ID: 27499541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of immune tolerance to allergens.
    Fujita H; Meyer N; Akdis M; Akdis CA
    Chem Immunol Allergy; 2012; 96():30-38. PubMed ID: 22433368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological mechanisms of allergen-specific immunotherapy.
    Jutel M; Akdis CA
    Allergy; 2011 Jun; 66(6):725-32. PubMed ID: 21466562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of allergen immunotherapy.
    Şahin E; Bafaqeeh SA; Güven SG; Çetinkaya EA; Muluk NB; Coşkun ZO; Lopatin A; Kar M; Pinarbasli MO; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):1-3. PubMed ID: 27658024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal Nanoemulsion Allergy Vaccine Suppresses Alarmin Expression and Induces Bystander Suppression of Reactivity to Multiple Food Allergens.
    Farazuddin M; Landers JJ; Janczak KW; Lindsey HK; Finkelman FD; Baker JR; O'Konek JJ
    Front Immunol; 2021; 12():599296. PubMed ID: 33717078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel therapeutic strategies by regulatory T cells in allergy.
    Elkord E
    Chem Immunol Allergy; 2008; 94():150-157. PubMed ID: 18802345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy.
    Gueguen C; Bouley J; Moussu H; Luce S; Duchateau M; Chamot-Rooke J; Pallardy M; Lombardi V; Nony E; Baron-Bodo V; Mascarell L; Moingeon P
    J Allergy Clin Immunol; 2016 Feb; 137(2):545-58. PubMed ID: 26522402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergen-specific immunotherapy: an update on immunological mechanisms of action.
    Ciprandi G; Marseglia GL; Tosca MA
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):34-7. PubMed ID: 16700191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease.
    Rolland JM; Prickett S; Gardner LM; O'Hehir RE
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):201-22. PubMed ID: 23597085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergen-specific immunotherapy: is it vaccination against toxins after all?
    Bachmann MF; Kündig TM
    Allergy; 2017 Jan; 72(1):13-23. PubMed ID: 27558586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis.
    Kirmaz C; Ozenturk Kirgiz O; Bayrak P; Yilmaz O; Vatansever S; Ozbilgin K; Onur E; Celik O; Sogut A; Ay G; Yuksel H
    Eur Cytokine Netw; 2011 Mar; 22(1):15-23. PubMed ID: 21421451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergen-specific T lymphocytes as targets for specific immunotherapy: striking at the roots of type I allergy.
    Bohle B
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):233-41. PubMed ID: 12371619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
    Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
    J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more.
    Verhagen J; Blaser K; Akdis CA; Akdis M
    Immunol Allergy Clin North Am; 2006 May; 26(2):207-31, vi. PubMed ID: 16701141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticle based-immunotherapy against allergy.
    Gamazo C; Gastaminza G; Ferrer M; Sanz ML; Irache JM
    Immunotherapy; 2014; 6(7):885-97. PubMed ID: 25290419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
    von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
    Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.